Table 3.
Multivariate analysis of progression-free survival in the validation cohort.
Characteristic | HRa | 95% CIb | P-value |
---|---|---|---|
WHO Performance status | |||
0 | Ref | ||
1–2 | 1.43 | 0.98, 2.08 | 0.061 |
ctDNA | |||
ctDNA negative | Ref | ||
ctDNA positive | 1.50 | 1.03, 2.18 | 0.034 |
CA19.9_median | |||
≤1366 | Ref | ||
>1366 | 1.36 | 0.96, 1.92 | 0.085 |
Bold values indicate statistical significance p < 0.05.
Analysis was performed after stratification on studies and centers.
aHR Hazard ratio.
bCI confidence interval.